Dan Lu
Impact in
-
- Monoclonal and Polyclonal Antibodies Research
- Oncology top 10%
- HER2/EGFR in Cancer Research
- Cancer Immunotherapy and Biomarkers
Papers in
-
- Monoclonal and Polyclonal Antibodies Research 12
- Oncology 11
- HER2/EGFR in Cancer Research 8
- Cancer Treatment and Pharmacology 2
- Co-authors
- Zhenping Zhu (8 shared papers)Peter Böhlen (7 shared papers)Sandhya Girish (15 shared papers)Larry Witte (6 shared papers)Xenia Jimenez (6 shared papers)Amita Joshi (5 shared papers)Haifan Zhang (4 shared papers)Manish Gupta (3 shared papers)
- Journals
- Cancer Chemotherapy and Pharmacology (7 papers)Clinical Pharmacokinetics (3 papers)Blood (2 papers)CPT Pharmacometrics & Systems Pharmacology (2 papers)Journal of Biological Chemistry (2 papers)
- Partner nations
- ChinaUnited StatesSwitzerland
In The Last Decade
Dan Lu
50 papers receiving 2.0k citations
Peers
Comparison fields: 5 of 75
- Radiology, Nuclear Medicine and Imaging 547
- Oncology 239
- Infectious Diseases 96
- Molecular Biology 250
- Endocrinology, Diabetes and Metabolism 45
Countries citing papers authored by Dan Lu
This map shows the geographic impact of Dan Lu's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Dan Lu with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Dan Lu more than expected).
Fields of papers citing papers by Dan Lu
This network shows the impact of papers produced by Dan Lu. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Dan Lu. The network helps show where Dan Lu may publish in the future.
Co-authors
The 25 scholars most cited alongside Dan Lu, linked wherever they have co-authored with each other. Click a name or a connecting line to browse the papers they share.
All Works
Showing the 20 most-cited of 50 papers — load more, or switch the sort, to bring in the rest.
| # | Work | ||
|---|---|---|---|
| 1 | 2012 | 219 | |
| 2 | 2005 | 163 | |
| 3 | 2012 | 135 | |
| 4 | 2004 | 113 | |
| 5 | 2021 | 111 | |
| 6 | 2005 | 103 | |
| 7 | Inhibition of vascular endothelial growth factor-induced receptor activation with anti-kinase insert domain-containing receptor single-chain antibodies from a phage display library. | 1998 | 96 |
| 8 | 2014 | 74 | |
| 9 | 2024 | 62 | |
| 10 | 2021 | 61 | |
| 11 | 2004 | 57 | |
| 12 | 2019 | 54 | |
| 13 | 2021 | 52 | |
| 14 | 2014 | 51 | |
| 15 | 1999 | 45 | |
| 16 | Complete inhibition of vascular endothelial growth factor (VEGF) activities with a bifunctional diabody directed against both VEGF kinase receptors, fms-like tyrosine kinase receptor and kinase insert domain-containing receptor. | 2001 | 45 |
| 17 | 2011 | 45 | |
| 18 | 2016 | 45 | |
| 19 | 2014 | 41 | |
| 20 | 2003 | 36 |
About Dan Lu
Dan Lu is a scholar working on Radiology, Nuclear Medicine and Imaging, Oncology, Molecular Biology, Pathology and Forensic Medicine and Infectious Diseases, having authored 50 papers that have together received 2.2k indexed citations. Recurring topics across this work include Monoclonal and Polyclonal Antibodies Research (12 papers), HER2/EGFR in Cancer Research (8 papers), Angiogenesis and VEGF in Cancer (4 papers), Protein Hydrolysis and Bioactive Peptides (3 papers), Lymphoma Diagnosis and Treatment (2 papers), Cancer Treatment and Pharmacology (2 papers), SARS-CoV-2 and COVID-19 Research (2 papers) and Phytochemistry and biological activity of medicinal plants (1 paper). The work is most often cited by research in Radiology, Nuclear Medicine and Imaging (547 citations), Oncology (239 citations), Infectious Diseases (96 citations), Molecular Biology (250 citations) and Endocrinology, Diabetes and Metabolism (45 citations). Dan Lu has collaborated with scholars based in China, United States and Switzerland. Frequent co-authors include Zhenping Zhu, Peter Böhlen, Sandhya Girish, Larry Witte, Xenia Jimenez, Amita Joshi, Haifan Zhang, Manish Gupta, Joo‐Hee Yi and Chunze Li. Their work appears in journals such as Cancer Chemotherapy and Pharmacology, Clinical Pharmacokinetics, Blood, CPT Pharmacometrics & Systems Pharmacology and Journal of Biological Chemistry.
Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.